Top Clinical Trials companies in Israel by Free Cash Flow

This ranking features the top 11 Clinical Trials companies in Israel ranked by Free Cash Flow, totalling a Free Cash Flow of USD -187.70 M, for January 15, 2025.
#
Name
Free Cash Flow
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD -6.14 M
Dec. 31, 2023 USD 2.82 -2.08%

Israel

2
USD -6.69 M
Dec. 31, 2023 USD 2.74 -3.52%

Israel

3
USD -7.33 M
Dec. 31, 2023 USD 2.36 -1.67%

Israel

4
USD -8.44 M
Dec. 31, 2023 USD 0.01 0.04%

Israel

5
USD -8.48 M
Dec. 31, 2023 USD 1.03 -0.96%

Israel

6
USD -19.93 M
Dec. 31, 2023 USD 0.02 -1.36%

Israel

7
USD -22.91 M
Dec. 31, 2023 USD 0.01 -11.50%

Israel

8
USD -23.61 M
Dec. 31, 2023 USD 1.90 -4.04%

Israel

9
USD -23.76 M
Dec. 31, 2023 USD 1.16 -2.88%

Israel

10
USD -24.36 M
Dec. 31, 2023 USD 4.00 8.11%

Israel

11
USD -36.06 M
Dec. 31, 2023 USD 1.85 10.75%

Israel

Frequently Asked Questions
  • Which Clinical Trials company in Israel has the highest Free Cash Flow ?

    The Clinical Trials company in Israel with the highest Free Cash Flow is Galmed Pharmaceuticals Ltd. (NasdaqCM: GLMD) at USD -6.14 M.

  • Which Clinical Trials company in Israel has the lowest Free Cash Flow ?

    The Clinical Trials company in Israel with the lowest Free Cash Flow is Compugen Ltd. (Tel Aviv Stock Exchange: CGEN.TA) at USD -36.06 M.